期刊文献+

丁酸氯维地平合成研究进展 被引量:1

Research Progress in Synthesis of Clevidipine Butyrate
下载PDF
导出
摘要 目的为简化丁酸氯维地平的合成步骤,优化合成路线,节约反应时间,降低工业成本提供参考.方法通过查找文献,对丁酸氯维地平的合成方法进行综述.结果丁酸氯维地平合成中所需的中间体4-(2,3-二氯苯基)-1,4-二氢-2,6-二甲基-3,5-吡啶二羧酸酯,它是通过Hantzsch法来制备的,然后再对所得中间体的侧链进行改造和修饰,本文系统地总结了以此为基础的三种合成方法,并探讨了其优缺点,以及独立于此之外新的合成方法.结论通过相关文献报道的合成方法总结梳理了氯维地平合成的研究进展,总结出满足于工业化生产要求的降低成本提高收率的丁酸氯维地平的合成方法. Objective To provide a reference for simplifying the synthesis steps of clevidipine butyrate,optimizing the synthesis route,saving reaction time,and reducing industrial costs.Methods The literature reviewed the synthesis method of clevidipine butyrate.Results 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate,an intermediate required for the synthesis of clevidipine butyrate.It is prepared by the Hantzsch method,and then the side chain of the obtained intermediate is modified.This paper systematically summarizes three synthetic methods based on this,and discusses their advantages and disadvantages,as well as independent new synthesis methods.Conclusion The research progress of the synthesis of clevidipine is summarized through the synthesis methods reported in related literatures,and the synthesis method of clevidipine butyrate which meets the requirements of industrial production and reduces the cost and improves the yield is summarized.
作者 李丽 赵僧群 韩莎莎 刘宇 LI Li;ZHAO Seng-qun;HAN Sha-sha;LIU Yu(College of Pharmacy,Liaoning University,Shenyang 110036,China)
机构地区 辽宁大学药学院
出处 《辽宁大学学报(自然科学版)》 CAS 2021年第1期38-45,共8页 Journal of Liaoning University:Natural Sciences Edition
关键词 丁酸氯维地平 合成路线 研究进展 工业化生产 clevidipine butyrate synthetic route research progress industrial production
  • 相关文献

参考文献18

二级参考文献107

  • 1张婧,纪宪勇,孙翔,王杰.氯维地平的合成[J].中国医药工业杂志,2011,42(7):484-486. 被引量:4
  • 2徐云根,华维一.尼莫地平的合成改进[J].中国医药工业杂志,2005,36(1):8-9. 被引量:6
  • 3徐云根,华维一,赵金慧,陈玉英,杨清华.非洛地平成品中杂质的分析和合成[J].中国药科大学学报,1995,26(2):65-67. 被引量:5
  • 4王玉民,曹晓群,朱焰,张昌军,庞现红.特戊酸氯甲酯合成新工艺的研究[J].泰山医学院学报,2005,26(4):346-347. 被引量:2
  • 5辜正一,朱源.西尼地平的合成工艺改进[J].中国现代应用药学,2006,23(3):204-205. 被引量:4
  • 6USFDA. FDAapprovalletter [ EB/QL]. [ 2008 - 08 - 01 ].http://www, fda. gov/cder/foi/appletter/2008/022156s0001tr. pdf.
  • 7SUH J J, HONG Y H. Synthesis of 1,4-dihydropyridine carboxylic acids ( II ) [ J ]. Yakhak Hoechi, 1989, 33 ( 4 ) : 219 -225.
  • 8SORBERA L A, CASTANER L Clevidipine: treatment of hypertension calcium channel blocker [ J ]. Drugs Fut, 2004,29 (2) :105 -111.
  • 9MATTSON A ,SVENSSON C,THORNBLOM K,et al. Manufacture of clevidipine from 4- ( 2', 3'-dichlorophenyl ) -1,4-di- hydro-5-methoxycarbonyl -2,6-dimethyl-3- pyridinecarboxylic acid: WO,2000/031035 [ P ]. 2000 - 06 - 02.
  • 10WHEELER T N,KENAKIN T P. Preparation of 4-aryl-1,4-dihydropyridine -3,5-dicarboxylates as vasodilators: US, 1992/ 5100892 [ P]. 1992 - 05 - 31.

共引文献32

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部